Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

US Administration Plans on Mapping the Human Brain

By BiotechDaily International staff writers
Posted on 11 Mar 2013
The Obama administration is planning a major scientific initiative, the mapping the human brain, to understand how it functions and malfunctions.

The initiative, dubbed the Brain Activity Map (BAM), will seek to map each of the approximately 100 billion neurons in the human brain, although initial studies will be performed in mice and other animals. The proposal for the project will be delivered to the US Congress as part of the president's budget package, and will carry a price tag of roughly USD 300 million a year over 10 years, totaling USD 3 billion. The effort is designed to be a collaboration between several federal agencies, including the National Institutes of Health (NIH; Bethesda, MD, USA), the National Science Foundation (NSF; Arlington, VA, USA), and private organizations.

News reports about the initiative indicated that a 2012 scientific commentary outlined experimental plans for the project, including a variety of specific experimental techniques that might be used to achieve what is termed as the functional connectome, as well as new technologies that will have to be developed in the course of the project. Initial studies might be done in Caenorhabditis elegans, followed by Drosophila, because of their comparatively simple neural circuits. Mid-term studies could be done in zebrafish, mice, and the Etruscan shrew, with studies ultimately to be done in primates and humans.

The project involves the development of nanoparticles that could be used as voltage sensors that would detect individual action potentials, as well as nanoprobes serving as electrophysiological multielectrode arrays. Other methods could use wireless, noninvasive methods of neuronal activity detection such as microelectronic very-large-scale integration and synthetic biology, rather than microelectronics. A related technique proposed the use of high-throughput DNA sequencing for rapidly mapping neural connectivity. The data would be analyzed and modeled by large scale computation. A description of the BAM project and the challenges it faces was published on February 22, 2013, in Neuron.

“To succeed, the BAM Project needs two critical components: strong leadership from funding agencies and scientific administrators, and the recruitment of a large coalition of interdisciplinary scientists,” concluded report coauthor Paul Alivisato, PhD, director of the Lawrence Berkeley National Laboratory (Berkeley, CA, USA), and colleagues. “We believe that neuroscience is ready for a large-scale functional mapping of the entire brain circuitry, and that such mapping will directly address the emergent level of function, shining much-needed light into the ‘impenetrable jungles’ of the brain.”

Related Links:

National Institutes of Health
National Science Foundation
Lawrence Berkeley National Laboratory



comments powered by Disqus

Channels

Genomics/Proteomics

view channel

New Program Encourages Wide Distribution of Genomic Data

A new data sharing program allows genomics researchers and practitioners to analyze, visualize, and share raw sequence data for individual patients or across populations straight from a local browser. The sequencing revolution is providing the raw data required to identify the genetic variants underlying rare diseases... Read more

Drug Discovery

view channel
Image: The nano-cocoon drug delivery system is biocompatible, specifically targets cancer cells, can carry a large drug load, and releases the drugs very quickly once inside the cancer cell. Ligands on the surface of the \"cocoon\" trick cancer cells into consuming it. Enzymes (the “worms\" in this image) inside the cocoon are unleashed once inside the cell, destroying the cocoon and releasing anticancer drugs into the cell (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Novel Anticancer Drug Delivery System Utilizes DNA-Based Nanocapsules

A novel DNA-based drug delivery system minimizes damage to normal tissues by utilizing the acidic microenvironment inside cancer cells to trigger the directed release of the anticancer drug doxorubicin (DOX).... Read more

Lab Technologies

view channel

Experimental Physicists Find Clues into How Radiotherapy Kills Cancer Cells

A new discovery in experimental physics has implications for a better determination of the process in which radiotherapy destroys cancer cells. Dr. Jason Greenwood from Queen’s University Belfast (Ireland) Center for Plasma Physics collaborated with scientists from Italy and Spain on the work on electrons, and published... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.